Updates to Keep an Eye on

August 16, 2023

The FDA has fast-tracked approval of Pfizer’s Elfrexfio drug for hard-to-treat multiple myeloma, offering new hope to patients. State and local governments are currently wrestling with how best to distribute funding from opioid crisis-related settlements as public health groups question the allocation to law enforcement. In New Zealand, all remaining COVID-19 restrictions have now been abolished, including face masks in hospitals, marking the end of their stringent pandemic control measures. Meanwhile, a study has indicated that users of skin-lightening products remain largely unaware of potential harm and often harbor biases towards lighter skin tones. Finally, due to insufficient evidence of fiscal difficulties, a judge rejected Johnson & Johnson’s talc business’s second bankruptcy attempt.

To read more, click here.

[Source: MM+M, August 15th, 2023]

Share This Story!